From Kanagawa to Kendall Square: iPS Cells, Wearable Cyborgs, and the Science of ME-BYO

Join the Kanagawa Prefectural Government and the Consulate-General of Japan in Boston at CIC Cambridge for an afternoon of regenerative medicine, medical robotics, and a new science of staying healthy — direct from Japan's life science gateway. A decade ago, facing the world's most rapidly aging society, Kanagawa made an unusual bet. Instead of treating health and disease as binary, its Healthcare New Frontier policy built an entire innovation ecosystem around the concept of ME-BYO , the measurable continuum between the two, where intervention is earliest, cheapest, and most effective. The results now speak Kendall Square's language. One of the world's first iPS cell-based clinical trials for subacute spinal cord injury, completed at Keio University. The wearable cyborg HAL, in clinical use from Tsukuba to the US and worldwide. Dynamic Chest X-ray technology, brought from concept to market through a decade of corporate-sponsored research at Brigham and Women's Hospital, sparked by a Kanagawa initiative. And two thriving landing pads for global collaboration: KING SKYFRONT in…